{"id":"https://openalex.org/W4362609682","doi":"https://doi.org/10.1158/1535-7163.22504570","title":"Supplemental Figure 6 from Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3\u2013Positive Acute Myeloid Leukemia","display_name":"Supplemental Figure 6 from Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3\u2013Positive Acute Myeloid Leukemia","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362609682","doi":"https://doi.org/10.1158/1535-7163.22504570"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22504570","doi":"https://doi.org/10.1158/1535-7163.22504570","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22504570","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22504570","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006727597","display_name":"Kristen M. Smith","orcid":"https://orcid.org/0000-0003-0960-0937","observed_orcids":["https://orcid.org/0000-0003-0960-0937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristen M. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021827432","display_name":"Patrick C. Fagan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick C. Fagan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028198430","display_name":"Elena Pomari","orcid":"https://orcid.org/0000-0002-5182-0231","observed_orcids":["https://orcid.org/0000-0002-5182-0231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Pomari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102711302","display_name":"Giuseppe German\u00f2","orcid":"https://orcid.org/0000-0001-6182-6007","observed_orcids":["https://orcid.org/0000-0001-6182-6007"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Germano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021966173","display_name":"Chiara Frasson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiara Frasson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Colin Walsh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin Walsh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028356265","display_name":"Ian M. Silverman","orcid":"https://orcid.org/0000-0003-3819-6726","observed_orcids":["https://orcid.org/0000-0003-3819-6726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian Silverman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052092177","display_name":"Paolo Bonvini","orcid":"https://orcid.org/0000-0003-2889-108X","observed_orcids":["https://orcid.org/0000-0003-2889-108X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paolo Bonvini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100438760","display_name":"Gang Li","orcid":"https://orcid.org/0000-0003-0924-7950","observed_orcids":["https://orcid.org/0000-0003-0924-7950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/entrectinib","display_name":"entrectinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/etv6-ntrk3-fusion","display_name":"ETV6-NTRK3 fusion","score":0.9179999828338623},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/alk-inhibition","display_name":"ALK inhibition","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.875}],"concepts":[{"id":"https://openalex.org/C134139212","wikidata":"https://www.wikidata.org/wiki/Q24719927","display_name":"Trk receptor","level":4,"score":0.7729480266571045},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.697948157787323},{"id":"https://openalex.org/C2780833115","wikidata":"https://www.wikidata.org/wiki/Q14914527","display_name":"ETV6","level":4,"score":0.6444268226623535},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5465802550315857},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.5175209045410156},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4909982979297638},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.42608627676963806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2949402928352356},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2786039710044861},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14783871173858643},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.14414933323860168},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1272728145122528},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.104469895362854},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.09689769148826599},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.0693744421005249},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.054612696170806885}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22504570","doi":"https://doi.org/10.1158/1535-7163.22504570","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22504570","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22504570.v1","doi":"https://doi.org/10.1158/1535-7163.22504570.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22504570.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_6_from_Antitumor_Activity_of_Entrectinib_a_Pan-TRK_ROS1_and_ALK_Inhibitor_in_i_ETV6-NTRK3_i_Positive_Acute_Myeloid_Leukemia/22504570/1/files/39964393.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22504570","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_Figure_6_from_Antitumor_Activity_of_Entrectinib_a_Pan-TRK_ROS1_and_ALK_Inhibitor_in_i_ETV6-NTRK3_i_Positive_Acute_Myeloid_Leukemia/22504570","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22504570","doi":"https://doi.org/10.1158/1535-7163.22504570","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22504570","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362609682.pdf","grobid_xml":"https://content.openalex.org/works/W4362609682.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2771786250","https://openalex.org/W4392687881","https://openalex.org/W6922458807","https://openalex.org/W2559758751","https://openalex.org/W2885292615","https://openalex.org/W2586704604","https://openalex.org/W4392721815","https://openalex.org/W2740542770","https://openalex.org/W2995157974","https://openalex.org/W7218628904"],"abstract_inverted_index":{"Entrectinib":[0],"was":[1],"not":[2],"toxic":[3],"in":[4],"zebrafish":[5],"xenograft":[6],"assay.":[7]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-06T00:00:00"}